跳至主要内容
临床试验/NCT06716385
NCT06716385已完成不适用

A Prospective, Randomized, Double-blind, Parallel, Active-controlled Clinical Trial to Evaluate the Vision Correction Safety and Efficacy of MSiHy Silicone Hydrogel Soft Contact Lens

Visco Vision Inc.5 个研究点 分布在 1 个国家目标入组 134 人开始时间: 2024年10月9日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
134
试验地点
5
主要终点
Visual Correction

研究概览

简要总结

This is a prospective, randomized, double-blind, parallel, active-controlled, multi-center clinical study. The purpose is to evaluate the safety and effectiveness wearing "MSiHy Silicone Hydrogel Soft Contact Lens".

Subjects will be randomized in 1:1 ratio to wear either the investigational device "MSiHy Silicone Hydrogel Soft Contact Lens" or the control device Monthly Silicone Hydrogel Contact Lenses(oA)".

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Must be 18 years of age inclusive
  • Beside myopia and astigmatism, subjects with normal eyes and are not using any ocular medications (excluding ocular lubricants and artificial tears)
  • Best spectacle corrected visual acuity greater than or equal to 1.0 for both eyes
  • With +8.00D ~ -12.00 D spherical component myopia, and ≤1.00 astigmatism (based on manifest refraction measurements)
  • Have worn soft contact lens for at least 2 month prior to the study
  • Willing to comply with the required wearing time
  • Agree to comply with all study procedures, sign and date the informed consent form before starting the clinical study

排除标准

  • Anterior segment infection, inflammation or abnormality
  • Any active ocular disease that would affect contact lens wear or vision (such as acute and subacute inflammation of the anterior chamber of the eye, eye infection, uveitis, serious palpebral abnormality, corneal hypoesthesia, corneal epithelium abrasion, dry eye and tear duct defection, ocular allergies, highly suspected glaucoma) upon evaluation by the investigators or slit lamp findings
  • Currently using systemic or ocular medications that would contraindicate contact lens wear (such as glaucoma eye drops, steroid anti-inflammatory drops, eye ointments, eye gels and other eye medicines)
  • History of herpetic keratitis
  • History of refractive surgery, keratoconus or irregular cornea
  • Slit lamp findings that are not suitable for inclusion (Details of the grading standards for each eye condition are specified in CIP section 5.7.5)
  • A pathologically dry eye (Schirmer test 1 <5 mm)
  • Have participated in any contact lens or contact lens care product clinical trials within the previous 1 month (excluding questionnaire types and specimen collection)
  • Currently pregnant, lactating, or planning to be pregnant during the trial
  • Have experienced discomfort when wearing silicone hydrogel contact lens, or a known allergy to hyaluronic acid and sodium alginate
  • Allergy to any contact lens care product ingredient
  • Corrected visual acuity in either eye does not reach 1.0 when wearing the trial lens
  • Subjects who are judged by the investigators as unsuitable for the study

结局指标

主要结局

Visual Correction

时间窗: 3 months

The effectiveness of vision correction is defined by the proportion of subjects whose contact lens corrected visual acuity in both eyes is 1.0 or greater.

次要结局

  • Visual Correction(1 week, 2 week, 1 month and 2 months)
  • Change in refraction(1 week, 2 week, 1 month, 2 months and 3 months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (5)

Loading locations...

相似试验